Anidulafungin: a new addition to the antifungal armamentarium
نویسندگان
چکیده
10.2217/14750708.4.2.125 © 2 Invasive fungal infections continue to be associated with high rates of morbidity and mortality, primarily in the immunocompromised hosts. Candida and Aspergillus are the most common causes of invasive fungal disease; however, other fungi can also cause disease in humans. Current therapeutic options for the management of invasive fungal infections include the polyenes, triazoles and echinocandins. Anidulafungin is a new echinocandin antifungal drug with a favorable toxicity profile and minimal drug–drug interactions that has activity against Aspergillus and Candida, including azole-resistant strains.
منابع مشابه
Management of systemic fungal infections: alternatives to itraconazole.
For many years, amphotericin B and flucytosine have been the only antifungal agents for invasive fungal infections. Amphotericin B was the standard of care for most of these infections. However, its use was often associated with low efficacy and poor tolerance. Fortunately, the antifungal armamentarium has increased during the past two decades with the addition of several new agents. In additio...
متن کاملAnidulafungin: an evidence-based review of its use in invasive fungal infections
INTRODUCTION Anidulafungin is a new echinocandin antifungal agent with indications for use in esophageal candidiasis and candidemia. The mortality and morbidity associated with fungal infections in healthcare facilities necessitates the development of new treatment options for these diseases. AIMS This review assesses the pharmacology and evidence for the use of anidulafungin in the treatment...
متن کاملImpact of new antifungal breakpoints on antifungal resistance in Candida species.
We reviewed our antifungal susceptibility data for micafungin, anidulafungin, fluconazole, and voriconazole against Candida species and compared resistance rates determined by the previous and recently revised CLSI antifungal breakpoints. With the new breakpoints, resistance was significantly increased for micafungin (from 0.8% to 7.6%), anidulafungin (from 0.9% to 7.3%), and voriconazole (from...
متن کاملAdditive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.
OBJECTIVES To investigate the activities of two newer triazoles and two echinocandins combined with human phagocytes against Candida parapsilosis biofilms. METHODS An in vitro model of C. parapsilosis biofilms was used. Biofilms were grown on silicone elastomer discs in 96-well plates at 37°C for 72 h. Biofilms or planktonic cells were incubated with voriconazole, posaconazole, caspofungin or...
متن کاملCombination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
Voriconazole is a first-line agent for the treatment of invasive pulmonary aspergillosis. Isolates with elevated voriconazole MICs are increasingly being seen, and the optimal treatment regimen is not defined. We investigated whether the combination of voriconazole with anidulafungin may be beneficial for the treatment of A. fumigatus strains with elevated voriconazole MICs. We used an in vitro...
متن کامل